Sign Out
Wonder tablets are indicated for the treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.
Wonder tablets should only be prescribed to patients who meet all the following criteria: An intravaginal ejaculatory latency time (IELT) of less than two minutes; and Persistent or recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the patient wishes; and Marked personal distress or interpersonal difficulty as a consequence of PE; and Poor control over ejaculation; and A history of premature ejaculation in the majority of intercourse attempts over the prior 6 months.
Wonder tablets should be administered only as on-demand treatment before anticipated sexual activity. It should not be prescribed to delay ejaculation in men who have not been diagnosed with PE.
